Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks

ISSN： 1129-2369

Source： The Journal of Headache and Pain, Vol.12, Iss.2, 2011-04, pp. : 235-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine

By Russell Michael

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 135-136

Springer Publishing Company

Access to resources Recommend Favorite

Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine

By Aurora Sheena Diener Hans-Christoph Dodick David

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 137-138

Springer Publishing Company

Access to resources Recommend Favorite

Dispute settlement understanding on the use of BOTOX^® in chronic migraine

By Martelletti Paolo

The Journal of Headache and Pain, Vol. 12, Iss. 1, 2011-02 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite

Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience

By Farinelli I. Coloprisco G. Filippis S. Martelletti P.

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 407-412

Springer Publishing Company

Access to resources Recommend Favorite

PACAP38 induces migraine-like attacks in patients with migraine without aura

By Schytz Henrik Winther Birk Steffen Wienecke Troels Kruuse Christina Olesen Jes Ashina Messoud

Brain, Vol. 132, Iss. 1, 2009-01 ,pp. : 16-25

Oxford University Press

Access to resources Recommend Favorite